| |
|
|
|
Cleveland BioLabs Inc.  
|
|
1.42 0.01 (0.01%) |
08-19 15:59 |
|
Open: |
1.42 |
Pre close: |
1.41 |
Target:
|
1.78
|
|
High: |
1.5105 |
Low: |
1.42 |
Resistance:
|
1.53
1.60
|
|
Volume: |
10,366 |
Market Cap: |
16M |
Support:
|
1.41
1.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.43
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.45 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.52  |
Stochastic Oscillator |
%K(14,3):
|
14.04 |
|
MA(250): |
1.61 |
%D(3): |
8.77 |
|
Average Volume(K) |
3-Month: |
464
|
52-Week |
High:
|
2.16 |
|
10-Days: |
452 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
53.59 |
Change(%): |
-20.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.270 |
Return on Equity (ttm) |
-83.8 |
Shares Out. (M) |
11.30 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-42.6 |
Shares Float (M) |
4.73 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
58.14 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-29.3 |
% Held by Institutions |
5.41 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
-0.219 |
Shares Short (K) |
35 |
|
Book Value (p.s.) |
-0.260 |
EBITDA (p.s.) |
-0.304 |
P/E |
-5.48 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-5.69 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-3.92 |
P/S |
185822240.00 |
|
Operating Margin |
-347.87 |
Levered Free Cash Flow
(M) |
-2.96 |
P/CF |
-4.27 |
|
|
|
|
|
|
